Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2021, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2021-01-23
DOI
10.1155/2021/8816041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician
- (2020) Guoqing Hou et al. INFLAMMATORY BOWEL DISEASES
- miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5
- (2020) Jun Yao et al. BIOSCIENCE REPORTS
- TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity
- (2020) Stacey N. Harbour et al. Science Immunology
- Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice
- (2019) Graham J. Britton et al. IMMUNITY
- Mechanisms of Disease: Inflammatory Bowel Diseases
- (2019) Guilherme Piovezani Ramos et al. MAYO CLINIC PROCEEDINGS
- Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study
- (2019) Byong Duk Ye et al. LANCET
- Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease
- (2019) Uni Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The pathogenicity of Th17 cells in autoimmune diseases
- (2019) Keiko Yasuda et al. Seminars in Immunopathology
- The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells
- (2019) Sara Omenetti et al. IMMUNITY
- Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of IL-17 in asthma pathogenesis and its implications for the clinic
- (2019) Rakhee K Ramakrishnan et al. Expert Review of Respiratory Medicine
- Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
- (2019) June-Yong Lee et al. CELL
- MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease
- (2018) Xue Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
- (2018) Amy Hemperly et al. CLINICAL PHARMACOKINETICS
- Th17 plasticity and its relevance to inflammatory bowel disease
- (2018) Aito Ueno et al. JOURNAL OF AUTOIMMUNITY
- Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
- (2018) Stephen Hanauer et al. Clinical Gastroenterology and Hepatology
- Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
- (2018) María Chaparro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- IL-23 in inflammatory bowel diseases and colon cancer
- (2018) Markus F. Neurath CYTOKINE & GROWTH FACTOR REVIEWS
- ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases
- (2018) Doaa Glal et al. Frontiers in Immunology
- The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease
- (2018) Liming Mao et al. Frontiers in Immunology
- Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study
- (2017) Bruce E. Sands et al. GASTROENTEROLOGY
- Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
- (2017) Yoram Bouhnik et al. GUT
- Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells
- (2017) Katharina Essig et al. IMMUNITY
- Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis
- (2017) Caroline J. Voskens et al. INFLAMMATORY BOWEL DISEASES
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
- (2017) Brian G Feagan et al. LANCET
- TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis
- (2017) Jan Kempski et al. Frontiers in Immunology
- The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis
- (2017) Shigeru Kotake et al. Journal of Clinical Medicine
- The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages
- (2017) Karim Chebli et al. Scientific Reports
- Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity
- (2016) Kai Hildner et al. DIGESTIVE DISEASES
- Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney
- (2016) Christian F. Krebs et al. IMMUNITY
- Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation
- (2016) Pawan Kumar et al. IMMUNITY
- Inflammatory Bowel Disease Is More Common Than Earlier Studies Showed
- (2016) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
- (2016) M. Scott Harris et al. Journal of Crohns & Colitis
- Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B
- (2016) Qian Qian Liu et al. Journal of Digestive Diseases
- Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology
- (2016) Verena Brucklacher-Waldert et al. JOURNAL OF IMMUNOLOGY
- Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
- (2016) David R Withers et al. NATURE MEDICINE
- Egress of intestinal TH17 cells in autoimmune renal disease
- (2016) Susan J. Allison Nature Reviews Nephrology
- Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice
- (2016) Tze Guan Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-21 and T Cell Differentiation: Consider the Context
- (2016) Yuan Tian et al. TRENDS IN IMMUNOLOGY
- High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice
- (2016) Yingfeng Wei et al. Oncotarget
- Interleukin-22: Immunobiology and Pathology
- (2015) Jarrod A. Dudakov et al. Annual Review of Immunology
- T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production
- (2015) Jinfang Zhu CYTOKINE
- Genetics of Inflammatory Bowel Diseases
- (2015) Dermot P.B. McGovern et al. GASTROENTEROLOGY
- miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD
- (2015) Chong He et al. GUT
- Retinoic Acid Is Essential for Th1 Cell Lineage Stability and Prevents Transition to a Th17 Cell Program
- (2015) Chrysothemis C. Brown et al. IMMUNITY
- Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome
- (2015) Yangyang Li et al. MEDIATORS OF INFLAMMATION
- Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
- (2015) O J Harrison et al. Mucosal Immunology
- The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation
- (2015) Dan Lu et al. NATURE IMMUNOLOGY
- Oral SMAD7 Antisense Drug for Crohn's Disease
- (2015) Severine Vermeire NEW ENGLAND JOURNAL OF MEDICINE
- Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis
- (2015) Stacey N. Harbour et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Th17 cells in central nervous system autoimmunity
- (2014) Christopher Sie et al. EXPERIMENTAL NEUROLOGY
- tTregs, pTregs, and iTregs: similarities and differences
- (2014) Ethan M. Shevach et al. IMMUNOLOGICAL REVIEWS
- Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease
- (2014) Wenyu Jiang et al. INFLAMMATION RESEARCH
- Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission
- (2014) Dario Sorrentino et al. INFLAMMATORY BOWEL DISEASES
- The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex
- (2014) J. F. Wright et al. JOURNAL OF IMMUNOLOGY
- Targeting Th17 cells in autoimmune diseases
- (2014) Jianfei Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inflammatory bowel disease: Pathogenesis
- (2014) Yi-Zhen Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- IL-21 induces IL-22 production in CD4+ T cells
- (2014) Ada Yeste et al. Nature Communications
- Innate and adaptive immunity in inflammatory bowel disease
- (2013) Alessandra Geremia et al. AUTOIMMUNITY REVIEWS
- The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer
- (2013) Lequn Li et al. CLINICAL IMMUNOLOGY
- Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target
- (2013) Mariangela Allocca et al. CURRENT DRUG TARGETS
- The Role of Polymorphonuclear Leukocyte Trafficking in the Perpetuation of Inflammation During Inflammatory Bowel Disease
- (2013) Jennifer C. Brazil et al. INFLAMMATORY BOWEL DISEASES
- Increased Prevalence of Circulating Novel IL-17 Secreting Foxp3 Expressing CD4+ T Cells and Defective Suppressive Function of Circulating Foxp3+ Regulatory Cells Support Plasticity Between Th17 and Regulatory T Cells in Inflammatory Bowel Disease Patients
- (2013) Aito Ueno et al. INFLAMMATORY BOWEL DISEASES
- IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid
- (2013) Hayet Rafa et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Antimicrobial Peptides and Colitis
- (2012) Samantha Ho et al. CURRENT PHARMACEUTICAL DESIGN
- IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade
- (2012) Anupam Mitra et al. CYTOKINE
- Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease
- (2012) Ali Raza et al. Expert Review of Clinical Immunology
- Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
- (2012) Pierre Desreumaux et al. GASTROENTEROLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Neutralization of Membrane TNF, but Not Soluble TNF, Is Crucial for the Treatment of Experimental Colitis
- (2012) Clémentine Perrier et al. INFLAMMATORY BOWEL DISEASES
- A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis
- (2012) C J Kim et al. Mucosal Immunology
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Regulatory T-cell therapy is a safe and well-tolerated potential approach for treating refractory Crohn's disease
- (2012) Andy McLarnon Nature Reviews Gastroenterology & Hepatology
- The many faces of Th17 cells
- (2011) Anneli Peters et al. CURRENT OPINION IN IMMUNOLOGY
- Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
- (2011) Raja Atreya et al. GASTROENTEROLOGY
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Foxp3+ Regulatory T Cells Promote T Helper 17 Cell Development In Vivo through Regulation of Interleukin-2
- (2011) Yi Chen et al. IMMUNITY
- IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo
- (2011) Jonas Mudter et al. INFLAMMATORY BOWEL DISEASES
- Compartmentalized Expression of Th1 and Th17 Cytokines in Pediatric Inflammatory Bowel Diseases
- (2011) J. Verdier et al. INFLAMMATORY BOWEL DISEASES
- Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model
- (2011) Haruei Ogino et al. JOURNAL OF GASTROENTEROLOGY
- Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production
- (2011) T. Feng et al. JOURNAL OF IMMUNOLOGY
- Fate mapping of IL-17-producing T cells in inflammatory responses
- (2011) Keiji Hirota et al. NATURE IMMUNOLOGY
- Inflammatory Bowel Disease
- (2010) Arthur Kaser et al. Annual Review of Immunology
- The role of mucosal immunity and host genetics in defining intestinal commensal bacteria
- (2010) Jonathan Hansen et al. CURRENT OPINION IN GASTROENTEROLOGY
- Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases
- (2010) Zaruhi Hovhannisyan et al. GASTROENTEROLOGY
- Th17 Cytokines and the Gut Mucosal Barrier
- (2010) Christoph Blaschitz et al. JOURNAL OF CLINICAL IMMUNOLOGY
- γδ T cells protect against lung fibrosis via IL-22
- (2010) Philip L. Simonian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-17- and IFN- -Secreting Foxp3+ T Cells Infiltrate the Target Tissue in Experimental Autoimmunity
- (2010) M. Esposito et al. JOURNAL OF IMMUNOLOGY
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
- (2009) Ivaylo I. Ivanov et al. CELL
- Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease
- (2009) L. Rovedatti et al. GUT
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- Smad3 Differentially Regulates the Induction of Regulatory and Inflammatory T Cell Differentiation
- (2009) Gustavo J. Martinez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
- (2009) Nicola Eastaff-Leung et al. JOURNAL OF CLINICAL IMMUNOLOGY
- STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
- (2009) Geethanjali Pickert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
- (2009) H. Hamada et al. JOURNAL OF IMMUNOLOGY
- All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis
- (2009) Aiping Bai et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
- (2009) Sara Trifari et al. NATURE IMMUNOLOGY
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential role of Th17 cells in the pathogenesis ofinflammatory bowel disease
- (2009) Zhan-Ju Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense
- (2008) Naoko Satoh-Takayama et al. IMMUNITY
- Human interleukin 17–producing cells originate from a CD161+CD4+T cell precursor
- (2008) Lorenzo Cosmi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
- A microbial symbiosis factor prevents intestinal inflammatory disease
- (2008) Sarkis K. Mazmanian et al. NATURE
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- TNF-mediated inflammatory disease
- (2007) JR Bradley JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More